The longevity stack: where supplements end and clinical care begins.

Almost every client who walks through our door has a supplement stack of some kind. Some are well thought out. Some are forty bottles wide and seven years deep, accumulating without anyone ever asking what it is doing. Both are worth taking seriously, and both have a ceiling.

What the supplement stack does well

A clean basal stack, adequate vitamin D, magnesium glycinate at night, an omega-3 with a verified EPA and DHA profile, a B-complex if the labs justify it, creatine for lean mass and cognition, and a NAD precursor if you have already done the boring work, closes nutritional gaps the diet of a busy adult will reliably leave open. None of these is a longevity drug. All of them are insurance against making a smaller version of yourself.

The signal you want from this stack is straightforward: stable energy, good sleep, steady labs at re-baseline. If you have that, do not add more bottles. The marginal pill is almost never the one that moves you.

Where the supplement stack stops

Oral bioavailability is unkind to a long list of compounds people swallow hoping for clinical effect. Curcumin, resveratrol, glutathione, magnesium oxide, most NAD precursors below clinical doses, these reach blood concentrations far below what the studies you have read used. This is not a moral failing of supplements; it is gut chemistry and first-pass metabolism. There is a real ceiling.

An intravenous vitamin-therapy programme sidesteps the gut. The same dose of NAD, vitamin C or glutathione delivered by infusion reaches a clinically meaningful peak concentration, then declines over the hours that follow. That is not magic. It is pharmacology, and it is what makes the difference between a pill that does little and an infusion that produces a measurable next-morning lift in clients who needed it.

Four signals it is time to escalate

Signal one, labs that do not move despite a clean basal stack and consistent behaviour for six months. If hs-CRP is stubbornly high-normal and HRV is trending down while you are doing the work, the work has hit a ceiling supplements can't break.

Signal two, a chronic inflammatory condition that flares against the supplement regimen rather than with it. Arthritis, autoimmune flares, post-viral fatigue. These are the cases where the MSC programme earns its keep, because immunomodulation is what mesenchymal stem cells do.

Signal three, a family history or a methylation read that says the calendar is not on your side. If the biomarker panel is trending in a direction supplements cannot reverse, the conversation needs to widen.

Signal four, you are travelling for longevity already. If you are flying twice a year for an IV drip you could have refined into a programme, you are paying for hotels rather than for care. The right model is a structured baseline at the clinic, a programme that earns the trip, and follow-ups that arrive at home in your inbox.

What we do, in order, with a new client

We re-baseline first. We trim or replace whatever supplements are not pulling their weight. We address sleep, training and food before we add anything intravenous. Only then do we layer in the interventions clients flew to Bangkok for, infusions, MSC therapy, occasionally banking, structured aesthetics, under a physician who reviews the data, not a menu.

It is a slower start than most longevity tourism markets sell. It is also, in our experience, the only version of the work that compounds. Practice, not product, covered in longevity as a practice, not a product if you want the philosophy.